Inside Precision Medicine Marketplace Molecular Diagnostics Companion Diagnostic (CDx) Services

Q2 Solutions
Companion Diagnostic (CDx) Services

Now more than ever, drug developers need an experienced global partner to advance Companion Diagnostic (CDx), development, who understands how to navigate the technical, regulatory and commercialization nuances to enhance the chances of program success.  CDx enables more effective development of personalized medicine by identifying likely patient responders based on efficacy and safety. With an extensive instrument footprint in laboratories throughout the world, Q2 Solutions® can expediently service CDx requests utilizing a range of technologies: immunohistochemistry (IHC), fluorescence in situ hybridization (FISH) next generation sequencing (NGS), and quantitative polymerase chain reaction (PCR).

Q2 Solutions® has a venerable track record of successfully supporting drug developers and in-vitro diagnostic (IVD) companies in many global CDx programs, from the early stages of biomarker validation through clinical trials testing and commercialization.




Q2 Solutions

5927 S. Miami Blvd.
Suite 100 Morrisville, NC 27560 USA
919-405-2248
https://www.q2labsolutions.com





Features & Specs

  • Principal Investigators at each wholly-owned facility that specialize in specific CDx disciplines: Anatomic Pathology, Immunohistochemistry, Genomics and Flow Cytometry
  • CDx Training and Harmonized SOPs across global sites
  • Global logistics network to route samples into CDx labs for rapid TAT
  • Supported >150 CDx/IVD studies to-date across multiple methodologies
  • In-house global Anatomic Pathologists trained and proficient to report out complex IHC results.

Features & Specs

  • Principal Investigators at each wholly-owned facility that specialize in specific CDx disciplines: Anatomic Pathology, Immunohistochemistry, Genomics and Flow Cytometry
  • CDx Training and Harmonized SOPs across global sites
  • Global logistics network to route samples into CDx labs for rapid TAT
  • Supported >150 CDx/IVD studies to-date across multiple methodologies
  • In-house global Anatomic Pathologists trained and proficient to report out complex IHC results.